- Home
- DGLY vs PRFX Comparison
DGLY vs PRFX Comparison
Compare DGLY & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- PRFX
- Stock Information
- Founded
- DGLY 2004
- PRFX 2007
- Country
- DGLY United States
- PRFX Israel
- Employees
- DGLY N/A
- PRFX N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- PRFX Health Care
- Exchange
- DGLY Nasdaq
- PRFX Nasdaq
- Market Cap
- DGLY 3.2M
- PRFX 2.8M
- IPO Year
- DGLY N/A
- PRFX 2020
- Fundamental
- Price
- DGLY $1.96
- PRFX $1.41
- Analyst Decision
- DGLY
- PRFX Hold
- Analyst Count
- DGLY 0
- PRFX 1
- Target Price
- DGLY N/A
- PRFX N/A
- AVG Volume (30 Days)
- DGLY 222.7K
- PRFX 8.8M
- Earning Date
- DGLY 08-18-2025
- PRFX 09-30-2025
- Dividend Yield
- DGLY N/A
- PRFX N/A
- EPS Growth
- DGLY N/A
- PRFX N/A
- EPS
- DGLY N/A
- PRFX N/A
- Revenue
- DGLY $18,612,519.00
- PRFX N/A
- Revenue This Year
- DGLY N/A
- PRFX N/A
- Revenue Next Year
- DGLY $7.38
- PRFX N/A
- P/E Ratio
- DGLY N/A
- PRFX N/A
- Revenue Growth
- DGLY N/A
- PRFX N/A
- 52 Week Low
- DGLY $1.66
- PRFX $1.25
- 52 Week High
- DGLY $119.00
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- DGLY 49.76
- PRFX 47.36
- Support Level
- DGLY $1.77
- PRFX $1.33
- Resistance Level
- DGLY $2.06
- PRFX $1.47
- Average True Range (ATR)
- DGLY 0.16
- PRFX 0.10
- MACD
- DGLY 0.05
- PRFX -0.01
- Stochastic Oscillator
- DGLY 36.71
- PRFX 16.67
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.